Karen H. Lu, MD, Chair

The University of Texas M.D. Anderson Cancer Center

LuDr. Lu is Professor and Vice Chair of Prevention and Biomarker Research in the Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas M.D. Anderson Cancer Center, and also hold the H.E.B. Professorship of Cancer Research. She is Director of the Uterine Cancer Research Program and Principal Investigator of the Uterine Cancer Specialized Program of Research Excellence (SPORE), a large $10 million NIH grant focused on the prevention and treatment of Uterine Cancer.

She completed her gynecologic oncology fellowship at Brigham and Women’s Hospital/ Dana-Farber Cancer Institute. In addition to treating gynecologic cancer patients, she participates in research to apply laboratory-based findings to improving the care of uterine and ovarian cancer patients. She has received support for her research from the National Cancer Institute, the Lynne Cohen Foundation, the American Gynecologic and Obstetric Society, and the Ovarian Cancer Research Fund. Dr. Lu is also an international expert in hereditary gynecologic cancers, and co-directs the Clinical Cancer Genetics Program at MD Anderson.

Spotlight

Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.

Awareness

Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.

Research

The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.

Education

The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.